Mersana Therapeutics Inc. (MRSN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.53
-0.02 (-3.62%)
At close: Jan 22, 2025, 3:59 PM
0.53
-0.42%
After-hours Jan 22, 2025, 07:11 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
PE Ratio | -1.57 | -2.64 | -2.59 | -18.51 | -9.14 | -1.46 | -5.1 | -17.88 | -14.91 |
PS Ratio | 7.31 | 20.65 | 10.21K | 1.98K | 5.90 | 8.87 | 11.26 | 9.73 | 23.64 |
PB Ratio | 7.30 | 5.96 | 3.61 | 7.17 | 3.18 | 10.68 | 2.82 | -4.4 | -5.74 |
P/FCF Ratio | -1.57 | -10.64 | -3.12 | -21.77 | -3.64 | -1.66 | -4.51 | 8.03 | -23.88 |
P/OCF Ratio | -1.6 | -11.12 | -3.14 | -21.9 | -3.67 | -1.7 | -4.63 | 7.75 | -25.42 |
OCF/S Ratio | -4.58 | -1.86 | -3.26K | -90.21 | -1.61 | -5.21 | -2.43 | 1.25 | -0.93 |
Debt / Equity Ratio | 0.92 | 0.39 | 0.31 | 0.07 | 0.10 | n/a | n/a | n/a | n/a |
Quick Ratio | 3.36 | 3.49 | 3.97 | 8.62 | 4.21 | 1.07 | 3.69 | 3.60 | 1.19 |
Current Ratio | 3.36 | 3.49 | 3.97 | 8.62 | 4.21 | 1.01 | 3.69 | 3.60 | 1.19 |
Asset Turnover | 0.16 | 0.08 | 0.00 | 0.00 | 0.39 | 0.13 | 0.13 | 0.24 | 0.72 |
Interest Coverage | -41.97 | -61.51 | -133.95 | -244.25 | -124.87 | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -4.65 | -2.25 | -1.39 | -0.39 | -0.35 | -7.31 | -0.55 | 0.25 | 0.38 |
Return on Assets (ROA) | -0.76 | -0.62 | -0.82 | -0.32 | -0.25 | -0.82 | -0.3 | -0.13 | -1.14 |
Return on Capital (ROIC) | -1.05 | -0.84 | -1.07 | -0.36 | -0.35 | -7.23 | -0.4 | -0.18 | -4.45 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -302.3% | 96.51% | -306.91K% | -8.00K% | -30.66% | -465.56% | 94.71% | -27.16% | -106.13% |
Net Profit Margin | -465.8% | -780.78% | -393.50K% | -10.68K% | -64.57% | -606.54% | -220.62% | -54.43% | -158.59% |
Pretax Profit Margin | -465.8% | -768.26% | -395.49K% | -10.63K% | -66.97% | -606.54% | -220.62% | -54.43% | -158.59% |
Operating Profit Margin | -463.86% | -770.08% | -394.68K% | -10.59K% | -69.37% | -619.74% | -225.8% | -54.91% | -157.75% |
FCF Margin | -464.12% | -193.97% | -327.06K% | -9.08K% | -162.26% | -534.13% | -249.77% | 121.19% | -99% |
EBITDA Margin | -450.63% | -752.26% | -390.55K% | -10.47K% | -63.45% | -594.68% | -215.33% | -52.31% | -154.88% |